NVCR Q1 2025 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q1 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$155M+11.9% YoY

Gross Profit

$116M75.1% margin

Operating Income

-$38M-24.4% margin

Net Income

-$34M-22.1% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

-3.9%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$46M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$887M

Stockholders' Equity

$362M

Cash & Equivalents

$127M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$155M	$139M	+11.9%
Gross Profit	$116M	$105M	+11.1%
Operating Income	-$38M	-$42M	+8.8%
Net Income	-$34M	-$39M	+11.5%

Geographic Segments

UNITED STATES

$93M47%

International Markets

$57M29%

GERMANY

$19M9%

FRANCE

$18M9%

JAPAN

$9M4%

CHINA

$5M2%